Gotham Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Gotham Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-73,141	Closed	-$969K	–	1120
2017 Q4	$969K	Sell	73,141 -358,270	-83%	-$5.4M	0.01%	594
2017 Q3	$7.96M	Sell	431,411 -368,644	-46%	-$6.87M	0.12%	274
2017 Q2	$14.7M	Buy	800,055 +121,137	+18%	+$2.4M	0.21%	156
2017 Q1	$15.3M	Buy	678,918 +78,334	+13%	+$1.88M	0.19%	179
2016 Q4	$20.9M	Buy	600,584 +92,775	+18%	+$2.77M	0.27%	124
2016 Q3	$12.4M	Buy	507,809 +95,897	+23%	+$2.4M	0.16%	196
2016 Q2	$9.85M	Buy	411,912 +207,728	+102%	+$4.76M	0.12%	279
2016 Q1	$4.78M	Sell	204,184 -12,272	-6%	-$291K	0.05%	442
2015 Q4	$6.54M	Sell	216,456 -780,089	-78%	-$25.2M	0.07%	368
2015 Q3	$39.6M	Buy	996,545 +485,948	+95%	+$30.2M	0.39%	69
2015 Q2	$35.3M	Buy	+510,597	New	+$32.1M	0.29%	116

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gotham Asset Management's AMAG Position: Q1 2018 in Review

Gotham Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 73,141 shares — an estimated $969K sold.

Gotham Asset Management first reported a position in AMAG in Q2 2015 and held it in 11 quarters. The position peaked at $39.6M in Q3 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

Gotham Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Gotham Asset Management sold 73,141 AMAG Pharmaceuticals shares in Q1 2018, an estimated $969K.
Gotham Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 11 quarters.
Gotham Asset Management's AMAG Pharmaceuticals position peaked at $39.6M in Q3 2015.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Gotham Asset Management's 13F filing for Q1 2018, filed 15 May 2018.